EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+13.98%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5B
AUM Growth
+$5B
(+12%)
Cap. Flow
+$185M
Cap. Flow
% of AUM
3.71%
Top 10 Holdings %
Top 10 Hldgs %
30.17%
Holding
159
New
25
Increased
53
Reduced
17
Closed
16
Top Buys
| 1 |
Annexon
ANNX
|
$52.4M |
| 2 |
Ecolab
ECL
|
$46M |
| 3 |
GTM
ZoomInfo Technologies
GTM
|
$44.9M |
| 4 |
Cintas
CTAS
|
$44.3M |
| 5 |
Sprout Social
SPT
|
$37.7M |
Top Sells
| 1 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$53.4M |
| 2 |
Lennox International
LII
|
$43.6M |
| 3 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$40.3M |
| 4 |
SPLK
Splunk Inc
SPLK
|
$37.4M |
| 5 |
SMAR
Smartsheet Inc.
SMAR
|
$33.4M |
Sector Composition
| 1 | Healthcare | 41.81% |
| 2 | Technology | 24.56% |
| 3 | Industrials | 10.55% |
| 4 | Consumer Discretionary | 8.43% |
| 5 | Communication Services | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
ADC Therapeutics
ADCT
$370M
| $19.2M | 0.37% |
580,483
+430,483
| +287% | +$14.2M |
|
77
XPO
XPO
$14.8B
| $18.6M | 0.36% |
636,107
| – | – |
|
78
Intuitive Surgical
ISRG
$158B
| $17.7M | 0.35% |
75,000
| – | – |
|
79
Repligen
RGEN
$6.54B
| $17.6M | 0.34% |
119,000
| – | – |
|
80
Nurix Therapeutics
NRIX
$723M
| $17.4M | 0.34% |
+497,740
| New | +$17.4M |
|
81
89bio
ETNB
$1.37B
| $17.3M | 0.34% |
675,000
+100,000
| +17% | +$2.57M |
|
82
Regeneron Pharmaceuticals
REGN
$59.8B
| $17.3M | 0.34% |
30,900
| – | – |
|
83
Brookfield Renewable
BEPC
$5.92B
| $16.7M | 0.33% |
+427,800
| New | +$16.7M |
|
84
Phathom Pharmaceuticals
PHAT
$843M
| $16.5M | 0.32% |
450,000
| – | – |
|
|
CCXI
85
DELISTED
ChemoCentryx, Inc.
CCXI
| $16.3M | 0.32% |
297,000
+122,000
| +70% | +$6.69M |
|
86
Jamf
JAMF
$1.21B
| $16.2M | 0.32% |
+430,000
| New | +$16.2M |
|
|
XLRN
87
DELISTED
Acceleron Pharma Inc.
XLRN
| $16.1M | 0.31% |
142,900
| – | – |
|
88
Dianthus Therapeutics
DNTH
$781M
| $16M | 0.31% |
147,478
| – | – |
|
|
EIDX
89
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $16M | 0.31% |
317,417
+104,417
| +49% | +$5.28M |
|
90
ESSA Pharma
EPIX
$11.2M
| $15.3M | 0.3% |
2,335,169
+325,000
| +16% | +$2.13M |
|
91
Xenon Pharmaceuticals
XENE
$2.99B
| $14.1M | 0.28% |
1,274,100
| – | – |
|
92
Lamb Weston
LW
$7.88B
| $13.5M | 0.26% |
203,000
-5,600
| -3% | -$371K |
|
|
ALLK
93
DELISTED
Allakos
ALLK
| $13M | 0.26% |
160,000
| – | – |
|
|
CHMA
94
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $12.9M | 0.25% |
3,000,326
+2,036,326
| +211% | +$8.76M |
|
|
DCPH
95
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $12.5M | 0.24% |
243,000
| – | – |
|
96
Kura Oncology
KURA
$732M
| $12.3M | 0.24% |
+400,000
| New | +$12.3M |
|
97
McCormick & Company Non-Voting
MKC
$18.7B
| $12.2M | 0.24% |
125,200
+5,200
| +4% | +$505K |
|
98
Xencor
XNCR
$594M
| $11.6M | 0.23% |
300,000
| – | – |
|
99
Relay Therapeutics
RLAY
$709M
| $10.6M | 0.21% |
+250,000
| New | +$10.6M |
|
100
Ciena
CIEN
$13.4B
| $10.6M | 0.21% |
267,000
| – | – |
|